Clinical Trial Update: Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports a Phase 1/2 study evaluating a combination of carfilzomib and lenalidomide with dexamethasone in newly diagnosed, previously untre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (Kyprolis) (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-11-20